Virtus ETF Advisers’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,676
| Closed | -$368K | – | 305 |
|
|
2024
Q4 | $368K | Buy |
2,676
+100
| +4% | +$13.8K | 0.15% | 193 |
|
|
2024
Q3 | $385K | Hold |
2,576
| – | – | 0.18% | 207 |
|
|
2024
Q2 | $351K | Sell |
2,576
-596
| -19% | -$81.3K | 0.17% | 197 |
|
|
2024
Q1 | $480K | Buy |
3,172
+456
| +17% | +$68.9K | 0.25% | 180 |
|
|
2023
Q4 | $342K | Sell |
2,716
-652
| -19% | -$82.1K | 0.22% | 194 |
|
|
2023
Q3 | $315K | Sell |
3,368
-434
| -11% | -$40.6K | 0.19% | 197 |
|
|
2023
Q2 | $339K | Buy |
3,802
+1,266
| +50% | +$113K | 0.2% | 169 |
|
|
2023
Q1 | $272K | Buy |
2,536
+45
| +2% | +$4.83K | 0.15% | 264 |
|
|
2022
Q4 | $304K | Sell |
2,491
-409
| -14% | -$50K | 0.16% | 258 |
|
|
2022
Q3 | $299K | Buy |
2,900
+44
| +2% | +$4.54K | 0.12% | 276 |
|
|
2022
Q2 | $265K | Buy |
2,856
+134
| +5% | +$12.4K | 0.1% | 286 |
|
|
2022
Q1 | $319K | Hold |
2,722
| – | – | 0.14% | 171 |
|
|
2021
Q4 | $366K | Buy |
2,722
+1,141
| +72% | +$153K | 0.14% | 178 |
|
|
2021
Q3 | $252K | Sell |
1,581
-83
| -5% | -$13.2K | 0.11% | 218 |
|
|
2021
Q2 | $219K | Buy |
1,664
+23
| +1% | +$3.03K | 0.09% | 278 |
|
|
2021
Q1 | $211K | Buy |
1,641
+27
| +2% | +$3.47K | 0.09% | 319 |
|
|
2020
Q4 | $269K | Sell |
1,614
-601
| -27% | -$100K | 0.11% | 279 |
|
|
2020
Q3 | $342K | Sell |
2,215
-296
| -12% | -$45.7K | 0.18% | 190 |
|
|
2020
Q2 | $371K | Sell |
2,511
-606
| -19% | -$89.5K | 0.18% | 232 |
|
|
2020
Q1 | $351K | Sell |
3,117
-452
| -13% | -$50.9K | 0.14% | 207 |
|
|
2019
Q4 | $497K | Buy |
3,569
+1,471
| +70% | +$205K | 0.08% | 203 |
|
|
2019
Q3 | $202K | Sell |
2,098
-116
| -5% | -$11.2K | 0.04% | 251 |
|
|
2019
Q2 | $255K | Sell |
2,214
-2,036
| -48% | -$234K | 0.05% | 270 |
|
|
2019
Q1 | $500K | Sell |
4,250
-539
| -11% | -$63.4K | 1.06% | 29 |
|
|
2018
Q4 | $300K | Buy |
+4,789
| New | +$300K | 0.05% | 110 |
|